For treatment of brain tumors, it is pertinent to mention that NKCC1 is also involved in transport across the blood–brain barrier, and that mutation of NKCC1 can result in dysfunction of the brain [54,55]. The gene discussed is SLC12A2; the disease is brain neoplasm.